Taku Nakahara Ph.D., MBA
Chief Executive Officer
Dr. Nakahara began his career as a bioinformatics researcher before launching a biotech startup out of Hokkaido University in 2008, where he was co-founder and Director of Bioinformatics until 2014 in New Jersey, USA. Since then, he has invested in businesses and startups in Japan, working for a major FMCG enterprise and venture capitals in Japan and the US.
In 2020, Dr. Nakahara founded Metagen Therapeutics (MGTx) as CEO, striving to commercialize microbiome medicine and drug discovery seeds from Japanese academia and companies.
Dr. Nakahara currently resides in Sapporo where he also serves as a bio-business advisor for Sapporo City, facilitating activities to support the local bio-innovation ecosystem.
